(Q37787336)

23 August 2017

2 references

7 November 2019

21 January 2024

Tranexamic acid in cardiac surgery: is there a cause for concern? (English)

1 reference

23 August 2017

0 references

1 reference

7 November 2019

1 reference

David Royston

1

1 reference

23 August 2017

6 September 2010

3 references

23 August 2017

7 November 2019

21 January 2024

3 references

23 August 2017

7 November 2019

21 January 2024

14

1 reference

23 August 2017

5

1 reference

23 August 2017

194

1 reference

https://scigraph.springernature.com/pub.10.1186/cc9227

23 August 2017

0 references

cites work

High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

Antifibrinolytics in cardiac surgical patients receiving aspirin: a systematic review and meta-analysis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

Seizure After Infusion of Aminocaproic Acid

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

Studies on convulsants in the isolated frog spinal cord. I. Antagonism of amino acid responses

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3219240

The dose-response relationship of tranexamic acid

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20831841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/CC9227

1 reference

PMC publication ID

3219240

Dimensions Publication ID

23 August 2017

0 references

1 reference

PMC publication ID

3219240

23 August 2017

PubMed publication ID

20831841

1 reference

PMC publication ID

3219240